Elevance Health Corporate & Other Segment — Restructuring Charges increased by 3100.0% to $128.00M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
High charges indicate significant organizational change, which may be positive if it leads to future efficiencies but negative if it reflects ongoing distress or poor planning.
This metric tracks the non-recurring expenses recognized in the corporate segment due to organizational restructuring, s...
Commonly reported as 'special charges' or 'restructuring expenses' across the insurance and healthcare services industry.
elv_segment_corporate_other_restructuring_charges| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $57.50M | $57.50M | $57.50M | $57.50M | $0.00 | $0.00 | $165.00M | $0.00 | $0.00 | $0.00 | $4.00M | $128.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | -100.0% | — | — | — | >999% |
| YoY Change | — | — | — | — | -100.0% | -100.0% | +187.0% | -100.0% | — | — | -97.6% | — |